106 related articles for article (PubMed ID: 2877563)
1. Safety and efficacy of flestolol, a new ultrashort-acting beta-adrenergic blocking agent, for supraventricular tachyarrhythmias.
Steinberg JS; Katz RJ; Somberg JC; Keefe D; Laddu AR; Burge J
Am J Cardiol; 1986 Nov; 58(10):1005-8. PubMed ID: 2877563
[TBL] [Abstract][Full Text] [Related]
2. Esmolol: a new ultrashort-acting beta-adrenergic blocking agent for rapid control of heart rate in postoperative supraventricular tachyarrhythmias.
Gray RJ; Bateman TM; Czer LS; Conklin CM; Matloff JM
J Am Coll Cardiol; 1985 Jun; 5(6):1451-6. PubMed ID: 2860148
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of esmolol (ASL-8052: an ultrashort-acting beta-adrenergic blocking agent) for control of ventricular rate in supraventricular tachycardias.
Byrd RC; Sung RJ; Marks J; Parmley WW
J Am Coll Cardiol; 1984 Feb; 3(2 Pt 1):394-9. PubMed ID: 6141193
[TBL] [Abstract][Full Text] [Related]
4. Esmolol: safety and efficacy in postoperative cardiothoracic patients with supraventricular tachyarrhythmias.
Schwartz M; Michelson EL; Sawin HS; MacVaugh H
Chest; 1988 Apr; 93(4):705-11. PubMed ID: 2894920
[TBL] [Abstract][Full Text] [Related]
5. Effect of flestolol on ventricular rate during atrial fibrillation in Wolff-Parkinson-White syndrome.
Swerdlow CD; Peterson J; Liem LB
Am J Cardiol; 1988 Jul; 62(1):78-82. PubMed ID: 2898208
[TBL] [Abstract][Full Text] [Related]
6. Esmolol versus verapamil in the acute treatment of atrial fibrillation or atrial flutter.
Platia EV; Michelson EL; Porterfield JK; Das G
Am J Cardiol; 1989 Apr; 63(13):925-9. PubMed ID: 2564725
[TBL] [Abstract][Full Text] [Related]
7. Flestolol: an ultra-short-acting beta-adrenergic blocking agent.
Barton SD; Burge J; Turlapaty P; Laddu AR
J Clin Pharmacol; 1986 Mar; 26(S1):A36-A39. PubMed ID: 2870085
[TBL] [Abstract][Full Text] [Related]
8. Controlled beta-receptor blockade with flestolol: a novel ultrashort-acting beta-blocker.
Murthy VS; Hwang TF; Rosen LB; Gorczynski RJ
J Cardiovasc Pharmacol; 1987 Jan; 9(1):72-8. PubMed ID: 2434798
[TBL] [Abstract][Full Text] [Related]
9. Clinical electrophysiology of flestolol, a potent ultra short-acting beta blocker.
Swerdlow CD; Peterson J; Turlapaty P
Am Heart J; 1986 Jan; 111(1):49-53. PubMed ID: 2868646
[TBL] [Abstract][Full Text] [Related]
10. Tolerance and beta-adrenergic blocking activity of flestolol, a short-acting beta blocker.
Turlapaty P; Burge J; Hulse J; Achari R; Bell V; Mosberg H; Laddu A
Clin Pharmacol Ther; 1986 May; 39(5):543-9. PubMed ID: 3698462
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and pharmacodynamics of flestolol, a new short-acting, beta-adrenergic receptor antagonist.
Achari R; Drissel D; Hulse JD; Bell V; Turlapaty P; Laddu A; Matier WL
J Clin Pharmacol; 1987 Jan; 27(1):60-4. PubMed ID: 2890664
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of intravenous diltiazem in atrial fibrillation or atrial flutter.
Ellenbogen KA; Dias VC; Cardello FP; Strauss WE; Simonton CA; Pollak SJ; Wood MA; Stambler BS
Am J Cardiol; 1995 Jan; 75(1):45-9. PubMed ID: 7801862
[TBL] [Abstract][Full Text] [Related]
13. Combined use of esmolol and digoxin in the acute treatment of atrial fibrillation or flutter.
Shettigar UR; Toole JG; Appunn DO
Am Heart J; 1993 Aug; 126(2):368-74. PubMed ID: 8101692
[TBL] [Abstract][Full Text] [Related]
14. Electropharmacology of flestolol for supraventricular tachycardia without associated structural heart disease.
Swerdlow C; Peterson J; Liem LB; Blake K; Franz MR; Laddu A
Am J Cardiol; 1987 Nov; 60(13):1055-60. PubMed ID: 2890290
[TBL] [Abstract][Full Text] [Related]
15. Hemodynamic effects of flestolol, a titratable short-acting intravenous beta-adrenergic receptor blocker.
Strom J; Josephson M; Frishman WH; Singh B; Heilbrunn S; Osterle S; Turlapaty P; Viray R; Coe J; Bell V
J Clin Pharmacol; 1988 Mar; 28(3):276-82. PubMed ID: 2896204
[TBL] [Abstract][Full Text] [Related]
16. Antiarrhythmic activity of flestolol, a novel ultra-short-acting beta-adrenoceptor antagonist, in the dog.
Reynolds RD; Brown BS
Eur J Pharmacol; 1986 Nov; 131(1):55-66. PubMed ID: 2880726
[TBL] [Abstract][Full Text] [Related]
17. Clinical experience with esmolol, a short-acting beta-adrenergic blocker in cardiac arrhythmias and myocardial ischemia.
Sung RJ; Blanski L; Kirshenbaum J; MacCosbe P; Turlapaty P; Laddu AR
J Clin Pharmacol; 1986 Mar; 26(S1):A15-A26. PubMed ID: 2870082
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of cardioselective beta adrenergic blockade with intravenously administered tolamolol in the treatment of cardiac arrhythmias.
Amsterdam EA; Lee G; Morrison S; Tonkin MJ; DeMaria AN; Mason DT
Am J Cardiol; 1976 Aug; 38(2):195-9. PubMed ID: 7952
[TBL] [Abstract][Full Text] [Related]
19. Effects of flestolol, an ultra-short acting beta-adrenoceptor antagonist, on hemodynamic changes produced by treadmill exercise or isoprenaline stimulation in conscious dogs.
Grohs JG; Fischer G; Raberger G
J Cardiovasc Pharmacol; 1990 Feb; 15(2):175-81. PubMed ID: 1689410
[TBL] [Abstract][Full Text] [Related]
20. Metoprolol in the treatment of supraventricular tachyarrhythmias.
Möller B; Ringqvist C
Ann Clin Res; 1979 Feb; 11(1):34-41. PubMed ID: 453778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
